# Rebuilding the health record: medicine's missing feedback loop

> Your health is a set of facts and the relationships between them. The places to write that down exist, and are mostly empty. Here is what changes when they are filled in.

- Canonical URL: https://www.meetkin.com/engineering/rebuilding-the-health-record
- Section: [Kin Engineering](https://www.meetkin.com/engineering)
- Written by: Kyle Alwyn and Rahul Devathu
- Published: 2026-11-11
- Published by: Kin Health (https://www.meetkin.com)

Medicine is great at producing information about you and bad at keeping it connected. A symptom gets said out loud in an exam room. A lab value lands in a portal. A prescription goes to a pharmacy. Whether the prescription worked is known, eventually, by you. Usually by nobody else.

That last part is the whole problem. Medicine gets better by finding out what happened to one patient and doing better for the next. Right now it mostly doesn't find out.

The one person who does is the patient. Health systems change. Specialists change. The friends giving advice change. The patient is the only one in every room, and the only one there between the rooms. That makes them the natural quarterback of their own care, and they're playing without the tools or the data.

The health graph is our attempt to give them both, one person at a time.

## A record in pieces

Start with how scattered it is. In a year, the median Medicare patient sees [seven physicians across four practices](https://www.nejm.org/doi/full/10.1056/NEJMsa063979). Among US adults, [59% have more than one patient portal, and 7% use anything to bring them together](https://healthit.gov/data/data-briefs/individuals-access-and-use-patient-portals-and-smartphone-health-apps-2024/).

Moving documents around is the easy part, though. The hard part is that the documents don't say how their contents relate. Take the simplest relationship in medicine: what a drug is for. In a study of 4.4 million outpatient prescriptions, the reason was written on [7.4% of them](https://pubmed.ncbi.nlm.nih.gov/31361884/). The field exists. It's just empty.

This isn't a new idea. In 1968 Lawrence Weed argued in the New England Journal of Medicine that [every note, order, and result should be filed under the problem it belongs to](https://www.nejm.org/doi/full/10.1056/NEJM196803142781105). The idea won as a format (the problem list, the SOAP note) and lost as a structure. The links stayed in clinicians' heads.

And that's only what happens inside the system. Health goes home with you. It goes to the dentist, the therapist, the kitchen, bed. How you slept, what you ate, whether the pain was better on the days you walked. Most of what decides how someone actually feels never makes it into a chart.

Meanwhile the person holding it all together is working from memory. A week after a specialist visit, patients recalled [about half of what was decided](https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0191940). When patients can read their notes, [one in five finds a mistake](https://pubmed.ncbi.nlm.nih.gov/32515797/).

## The loop, as it runs today

Follow one therapy through the system.

It gets prescribed. Somewhere between [one in seven and one in four new prescriptions](https://pmc.ncbi.nlm.nih.gov/articles/PMC2842539/) is never filled, and the prescriber often doesn't find out. If it is taken, whether it worked is observed at home, weeks later, by the patient. If it causes harm, the reporting systems built to catch that miss [a median 94% of adverse reactions](https://pubmed.ncbi.nlm.nih.gov/16689555/).

For that outcome to change anyone else's care, a study has to pick it up. Trials in the leading journals [exclude people with common medical conditions 81% of the time](https://pubmed.ncbi.nlm.nih.gov/17374817/), so the hardest patients to treat are the least studied. Then the study has to become a guideline, and the guideline a habit. The number everyone quotes for that is 17 years. It's a [stitched-together estimate](https://pmc.ncbi.nlm.nih.gov/articles/PMC3241518/), but when the National Cancer Institute actually measured it for five cancer-control practices, it [found an average of 15](https://pubmed.ncbi.nlm.nih.gov/33392908/).

**Figure: How long the loop takes, by where you ask**

- Another patient replies: 3 hours. Median time to a first reply, one health community on Reddit.
- A clinician can see you: 31 days. Average wait for a new-patient appointment, six specialties, 15 large US metros.
- Evidence becomes practice: 15 years. Average from landmark study to half of eligible patients, five cancer-control practices.

Logarithmic scale. Reply time: Nobles and others, [JAMA, 2019](https://jamanetwork.com/journals/jama/fullarticle/2753884), one community, r/STD. Appointment wait: AMN Healthcare, [2025 survey of physician appointment wait times](https://www.amnhealthcare.com/siteassets/amn-insights/physician/ps-2025-physician-appt-wait-times---wp-v6.pdf), a phone survey of 1,391 offices. Research to practice: Khan, Chambers and Neta, [Cancer Causes & Control, 2021](https://pubmed.ncbi.nlm.nih.gov/33392908/), a range of 13 to 21 years. Three measurements of three different things, set side by side for scale.

To be fair, it can be fast. The RECOVERY trial went from its first patient to a dexamethasone result [in about three months](https://theconversation.com/the-inside-story-of-recovery-how-the-worlds-largest-covid-19-trial-transformed-treatment-and-what-it-could-do-for-other-diseases-184772), and the NHS adopted it the same day. But that took a pandemic. And the [big surveillance systems](https://www.sentinelinitiative.org/about/key-database-statistics) run on insurance claims, which record what was dispensed and billed, not how the person did.

## Patients are already running the loop

If you want to see what this costs, don't look at a hospital. Look at Reddit.

[r/ADHD](https://www.reddit.com/r/ADHD/) had 600,000 visitors the week we looked. The GLP-1 communities, most of them a few years old, [add up to more than a million and a half memberships](https://michelnivard.github.io/GLP-1-chatter/methods/). [r/Retatrutide](https://www.reddit.com/r/Retatrutide/) drew 138,000 visitors that week, for a drug that hasn't been approved.

Spend an hour in any of them and the same post shows up over and over. Here's what I have, here's what I was given, here's what happened, has anyone else seen this? Then the replies. I tried that, it took six weeks, the fatigue got worse first, ask about the other dose.

[31% of US adults](https://www.kff.org/public-opinion/kff-tracking-poll-on-health-information-and-trust-use-of-social-media-and-ai-for-health-information-and-advice/) now use social media for health information or advice at least monthly. Asked why, the top answers are learning from people with the same condition (36%) and wanting an answer now (35%). Cost and not having a regular provider come well behind (17%). People aren't mainly there because they can't get in the door. They're there for two things the system doesn't offer: what happened to people like me, and soon. [About a third](https://www.kff.org/public-opinion/kff-tracking-poll-on-health-information-and-trust-use-of-ai-for-health-information-and-advice/) have now asked an AI chatbot the same questions.

That's not recklessness. It's people doing science with the only instruments they have, and sometimes they get there first. People with type 1 diabetes built their own automated insulin delivery and [published results in 2016](https://pmc.ncbi.nlm.nih.gov/articles/PMC5094342/). A randomized trial in the New England Journal of Medicine [confirmed it worked in 2022](https://www.nejm.org/doi/full/10.1056/NEJMoa2203913), and the FDA cleared [the first app that began as a patient-led project](https://www.tidepool.org/blog/tidepool-loop-has-received-fda-clearance) in 2023. People with long COVID ran a [study of 3,762 people in 56 countries](https://www.thelancet.com/journals/eclinm/article/PIIS2589-5370(21)00299-6/fulltext) from a support group and catalogued 203 symptoms while formal research was still getting organized.

But a forum has no denominators, no way to tell someone like you from someone who isn't, and no memory beyond the thread. A [review of 100 studies](https://www.nature.com/articles/s44271-025-00217-6) found online support groups help people socially, with inconclusive effects on physical health. And self-experiment has casualties: the FDA has reported hospitalizations from people taking [five to twenty times the intended dose](https://www.fda.gov/drugs/human-drug-compounding/fda-alerts-health-care-providers-compounders-and-patients-dosing-errors-associated-compounded) of compounded semaglutide.

Right instinct, wrong instrument.

## What the graph is

Nearly everything worth knowing about someone's health is either a fact about them or a relationship between two facts. So that's what we store.

**A Fact is one thing that's true of one person.** A symptom, a condition, a medication, a lab result, a vital sign, a procedure, an allergy, a family history. Nineteen types in all. Every one carries the same spine:

- **What it is**, as a concept from a shared medical vocabulary, so "underactive thyroid" in one visit and "hypothyroidism" in another are the same thing.
- **How sure anyone is**: present, possible, or explicitly absent, with a confidence. "Ruled out" is knowledge too.
- **When it was true**, which isn't when it was recorded. A symptom that started in January and came up in March happened in January.
- **Who said so**: the clinician, the patient, a caregiver, or a device.

**An Edge is why one Fact bears on another.** There are five, on purpose: `evidence_for`, `treats`, `monitors`, `side_effect_of`, and `complication_of`. Five verbs turn a pile of findings into clinical reasoning.

**Every Fact and Edge comes from a Source.** A recorded visit, a photographed lab report, a discharge summary. Each one is read once and integrated as a single set of changes. Nothing is edited in place. When a later Source corrects an earlier one, the correction is added and the original is marked superseded. The graph can always say what it believed, when, and on what evidence.

The graph belongs to the person, not an institution. That follows from who's constant. A record kept by a health system ends at its walls. A record kept by the patient goes where they go, and can hold what only they saw.

Medicine already has graphs of medicine. Those say pneumonia causes cough. A graph of one person says this cough was evidence for this pneumonia, which was treated by this prescription, which was followed by this result. The literature calls that a personal health knowledge graph, and one survey notes [there's no standard model for one](https://arxiv.org/abs/2004.00071). It's an open area, and we'd rather say so.

## One person, one path

Here's what that looks like for one fictional person, across five Sources over eleven weeks.

**Figure: From a symptom to an outcome, as one path**

1. **A visit: one Fact.** She tells her doctor she has been exhausted for two months. The visit is the Source; the graph keeps a symptom Fact, attributed to the patient, timed to when it began rather than when it was said.
2. **A lab report: a second Source.** A photographed lab report arrives a week later. It becomes a lab result Fact with a value, a unit, and an interpretation. Nothing links it to the fatigue yet, and the graph does not pretend otherwise.
3. **A diagnosis: the first Edges.** At the next visit the clinician names the condition. Two evidence_for Edges now say why: the symptom and the lab result both point at it. The reasoning is stored, not just the conclusion.
4. **A therapy.** A medication Fact, joined to the condition by a treats Edge. From here on the record knows what this drug is for, which is what makes its outcome measurable.
5. **The feedback: an observation.** Eight weeks later a second lab result monitors the condition. The loop has closed once: a therapy went in, a measurement came out, and both sit on the same condition.
6. **And what it cost.** A new symptom, joined to the medication by a side_effect_of Edge. Benefit and cost of one therapy for one person are now a path anyone with her permission can walk.

**Six Facts, five Edges, five Sources.** Read it as a path: a symptom and a lab result are evidence for a condition, a medication treats it, a later result monitors it, and a new symptom is that medication's side effect. Step through to watch it accumulate.

An illustrative record. The person and every value are fictional; the Fact types and the relations between them are the ones Kin's graph uses.

Nothing in it is exotic. Every item exists somewhere in a typical patient's paperwork. What's new is the lines, and the lines answer questions a folder of documents can't:

- Why am I taking this? Follow `treats` from the medication.
- What was this diagnosis based on? Follow `evidence_for` back to the Facts behind it.
- Is it working? Follow `monitors` to everything measured since.
- What has it cost me? Follow `side_effect_of`.

Those are the questions people bring to a forum at two in the morning. They're answerable from their own record, once the record has a shape.

## From one record to many

Now do that ten thousand times.

Every record with a path from a therapy, through the condition it treats, to what happened next is one completed turn of the loop. Put enough of them side by side, with each person's consent and without their identity, and you can ask a different question. Not "what does the guideline say," but "what happened to people who started this, and to the ones who look like me?"

**Figure: One therapy, a hundred records**

| Of 100 people | Everyone | With a second condition | Treated within 30 days |
| --- | --- | --- | --- |
| Improved, no side effect | 46 | 24 | 63 |
| Improved, with a side effect | 14 | 18 | 13 |
| No measurable change | 26 | 33 | 17 |
| Stopped the therapy | 14 | 25 | 7 |

- Everyone: The average is what a trial reports, and what a guideline is written from.
- With a second condition: The same therapy, a different answer. This group is often too small, or excluded, to show up in a trial.
- Treated within 30 days: Timing is in the graph too: every Fact carries when it was true, so how soon is a question you can ask.

Illustrative numbers, not Kin data and not a clinical finding. Each dot stands for one person out of 100 who started the same therapy.

The first view is the one medicine already has: the average effect. The other two are what it mostly lacks, because those people are too few, too complicated, or too far from a research center to end up in a trial. They're not too few to exist. They're just not connected.

Where a field has tracked what happened to every patient, the results are suggestive. Sweden's heart attack registry saw [30-day mortality fall from 15.0% to 8.6%](https://doi.org/10.1001/jama.2011.522) between 1996 and 2007, as evidence-based treatments spread and every hospital could see where it stood. Cancer patients who reported symptoms between visits, with their care team alerted, [lived a median of five months longer](https://jamanetwork.com/journals/jama/fullarticle/2630810). Neither proves measurement alone did it. Both show what opens up once outcomes are visible.

Paying for outcomes has the same dependency. Contracts that tie a drug's price to whether it works are stuck with outcomes that show up in insurance claims, which [leaves out most of what patients would call working](https://www.commonwealthfund.org/publications/issue-briefs/2017/sep/outcomes-based-pharmaceutical-contracts-answer-high-us-drug). You can't pay for outcomes you can't see.

## The missing piece of personalized medicine

Precision medicine is mostly about inputs: sequence the genome, measure more biomarkers, sort people into finer subgroups. Where one feature predicts response, that's worked spectacularly. But even in oncology, where it's worked best, genome-targeted drugs were estimated to benefit [about 5% of US patients with metastatic cancer](https://jamanetwork.com/journals/jamaoncology/fullarticle/2678901) in 2018.

Personalized medicine asks a different question. Not which subgroup you're in, but what works for you. And people really do respond differently. In a Swedish trial that rotated each participant through four blood pressure drugs, picking each person's best one would have lowered systolic pressure by [a further 4.4 mm Hg](https://jamanetwork.com/journals/jama/fullarticle/2803518). But it took repeated, blinded exposure of the same person to each drug to show it. An average effect [can't tell you who responded](https://www.nature.com/articles/d41586-018-07535-2). Only measuring the same person over time can.

A better input can't give you that. You find out what works for one person by trying something, seeing what happened, and adjusting. Medicine mostly skips the seeing.

So here's our argument, and it's an argument, not a consensus: personalized medicine is a learning problem, and nothing learns without feedback. A system that prescribes and rarely finds out how it went can't get much better at prescribing for you, however much it knows about you going in. And the one person there for every turn of that loop is the patient.

> **What a loop doesn't fix**
>
> Capturing outcomes is necessary, not sufficient. People take a treatment for reasons that also predict how they'll do: observational studies once suggested hormone therapy [roughly halved heart disease](https://pubmed.ncbi.nlm.nih.gov/1826173/), and the [randomized trial found harm](https://jamanetwork.com/journals/jama/fullarticle/195120). People blame what they feel on what they take: when patients who'd quit statins over side effects tracked symptoms daily under blinding, [90% of the symptom burden showed up on placebo too](https://www.nejm.org/doi/full/10.1056/NEJMc2031173). People who keep using an app aren't everyone: across eight remote studies, [median retention was 5.5 days](https://www.nature.com/articles/s41746-020-0224-8). And collecting outcomes [changes little unless someone acts on them](https://pubmed.ncbi.nlm.nih.gov/24072815/).
>
> There's also reason for measured optimism. When 32 randomized trials were emulated in insurance claims, the results [correlated at 0.82 overall](https://jamanetwork.com/journals/jama/fullarticle/2804067). Routine data can answer real questions when it holds the right things and the question is asked carefully. A graph doesn't remove those requirements. It's what makes them possible to meet.

## Where we're starting

We're not there, and we have no clinical findings to report. Today the graph does something smaller: it turns a person's visits and documents into one record they own, that they and the people caring for them can read, question, and correct. It gives the one person who's there for all of it something to run their care with. That's worth building on its own.

But the reason to build it as a graph, with Facts that carry their time and source and Edges that carry their reasons, is everything above. The loop has to close for one person before it can close for everyone. That's where we're starting.
